Drug resistance contributes to malaria mortality- Physician
By : NAN
Date:
16 August 2021 11:42am WAT
Share :
(FILES) In this file photo taken on February 26, 2020, medical staff shows o at the IHU Mediterranee Infection Institute in Marseille, packets of a Nivaquine, tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs that has shown signs of effectiveness against coronavirus. - On March 29, 2020,a limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients. In a statement published Sunday, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments. (Photo by GERARD JULIEN / AFP)
(FILES) In this file photo taken on February 26, 2020, medical staff shows o at the IHU Mediterranee Infection Institute in Marseille, packets of a Nivaquine, tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs that has shown signs of effectiveness against coronavirus. - On March 29, 2020,a limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients. In a statement published Sunday, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments. (Photo by GERARD JULIEN / AFP)
(FILES) Is n this file photo taken on February 26, 2020, medical staff shows packets of a Nivaquine, tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs. Photo/AFPA General Physician, Dr Saheed Adelaja , says resistance to antimalaria drugs contributes to malaria mortality.
Adelaja made the assertion on Monday in an interview with the News Agency of Nigeria (NAN) in Ibadan.
“Malaria is a major public health burden throughout the world. “Resistance to antimalarial drugs has increased the mortality despite the various malaria control programmes,” he said.
Adelaja said that although the efficacy of artemisinin-based combination therapies (ACTs) remained high, drug resistance to malaria had increased.
He said it had become important to monitor drug resistance in order to reduce malaria deaths in the country.
“Monitoring the drug resistance to the available antimalarial drugs helps to implement effective drug policy.
